Omalizumab: An update on efficacy and safety in moderate-to-severe allergic asthma

By Chipps Bradley E.   Figliomeni Maria   Spector Sheldon  

Allergy and Asthma Proceedings, Vol. 33, Iss. 5, 2012-09 ,pp. : 377-385

OceanSide Publications, Inc

Access to resources Recommend Favorite

Omalizumab and asthma control in patients with moderate-to-severe allergic asthma: A 6-year pragmatic data review

By Storms William   Bowdish Matthew S.   Farrar Judith R.  

Allergy and Asthma Proceedings, Vol. 33, Iss. 2, 2012-03 ,pp. : 172-177

OceanSide Publications, Inc

Access to resources Recommend Favorite

The effect of omalizumab on small airway inflammation as measured by exhaled nitric oxide in moderate-to-severe asthmatic patients

By Pasha M. Asghar   Jourd'heuil David   Jourd'heuil Francis   Mahon Lori   Romero Francisco   Feustel Paul J.   Evans Mary   Smith Thomas   Mitchell Jesse   Gendapodi Pradeep   DeMeyere-Coursey Kelly C.   Townley Robert G.  

Allergy and Asthma Proceedings, Vol. 35, Iss. 3, 2014-05 ,pp. : 241-249

OceanSide Publications, Inc

Access to resources Recommend Favorite

The Safety and Efficacy of ALLERVAX CAT in Cat Allergic Patients

By Maguire P.   Nicodemus C.   Robinson D.   Aaronson D.   Umetsu D.T.  

Clinical Immunology, Vol. 93, Iss. 3, 1999-12 ,pp. : 222-231

Academic Press

Access to resources Recommend Favorite

Clinical efficacy of omalizumab in an elderly veteran population with severe asthma

By Verma Prashant   Randhawa Inderpal   Klaustermeyer William B.  

Allergy and Asthma Proceedings, Vol. 32, Iss. 5, 2011-09 ,pp. : 346-350

OceanSide Publications, Inc

Access to resources Recommend Favorite